share_log

UBS Maintains Buy on Ovintiv, Raises Price Target to $70

Benzinga ·  May 15 09:57

UBS analyst Josh Silverstein maintains Ovintiv (NYSE:OVV) with a Buy and raises the price target from $69 to $70.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment